Hamouda Boussen

Hamouda Boussen

Auto-generated profile, based on publicly available information

Hamouda Boussen

Medical Oncology Department, Abderrahmane Mami Hospital, Faculty of Medicine, University of Tunis El Manar, Tunis, Tunisia

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2023 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
KAKhouloud Ayed
Khouloud Ayed
LNLamis Nabi
Lamis Nabi
Rym AkroutRym Akrout
Rym Akrout
HMHela Mrizak
Hela Mrizak
AGAmal Gorrab
Amal Gorrab
AGAsma GATI
Asma GATI

4 May 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MRMariem Ben Rekaya
Mariem Ben Rekaya
NLNadia Laroussi
Nadia Laroussi
OMOlfa Messaoud
Olfa Messaoud
MJMariem Jones
Mariem Jones
MJManel Jerbi
Manel Jerbi
HYHouda Yacoub-Youssef
Houda Yacoub-Youssef
Xeroderma pigmentosum Variant (XP-V) form is characterized by a late onset of skin symptoms. Our aim is the clinical and genetic investigations of XP-V Tunisian patients in order to develop a simple tool for early diagnosis. We investigated 16 suspected XP patients belonging to ten consanguineous families. Analysis of thePOLHgene was performed by linkage analysis, long range PCR, and sequencing. Genetic analysis showed linkage to thePOLHgene with a founder haplotype in all affected patients. Long range PCR of exon 9 to exon 11 showed a 3926 bp deletion compared to control individuals. Sequence analysis demonstrates that this deletion has occurred between two Alu-Sq2 repetitive sequences in the same orientation, respectively, in introns 9 and 10. We suggest that this mutationPOLHNG_009252.1: g.36847_40771del3925 is caused by an equal crossover event that occurred between two homologous chromosomes at meiosis. These results allowed us to develop a simple test based on a simple PCR in order to screen suspected XP-V patients. In Tunisia, the prevalence of XP-V group seems to be underestimated and clinical diagnosis is usually later. Cascade screening of this founder mutation by PCR in regions with high frequency of XP provides a rapid and cost-effective tool for early diagnosis of XP-V in Tunisia and North Africa.

25 March 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Maroua BoujemaaMaroua Boujemaa
Maroua Boujemaa
NMNajah Mighri
Najah Mighri
LCLotfi Chouchane
Lotfi Chouchane
MBMohamed Samir Boubaker
Mohamed Samir Boubaker
SASonia Abdelhak
Sonia Abdelhak
YHYosr Hamdi
Yosr Hamdi
Significant advances have been made to understand the genetic basis of breast cancer. High, moderate and low penetrance variants have been identified with inter-ethnic variability in mutation frequency and spectrum. Genome wide association studies (GWAS) are widely used to identify disease-associated SNPs. Understanding the functional impact of these risk-SNPs will help the translation of GWAS findings into clinical interventions. Here we aim to characterize the genetic patterns of high and moderate penetrance breast cancer susceptibility genes and to assess the functional impact of non-coding SNPs. We analyzed BRCA1/2, PTEN, STK11, TP53, ATM, BRIP1, CHEK2 and PALB2 genotype data obtained from 135 healthy participants genotyped using Affymetrix Genome-Wide Human SNP-Array 6.0. Haplotype analysis was performed using Haploview.V4.2 and PHASE.V2.1. Population structure and genetic differentiation were assessed using principal component analysis (PCA) and fixation index (FST). Functional annotation was performed using In Silico web-based tools including RegulomeDB and VARAdb. Haplotype analysis showed distinct LD patterns with high levels of recombination and haplotype blocks of moderate to small size. Our findings revealed also that the Tunisian population tends to have a mixed origin with European, South Asian and Mexican footprints. Functional annotation allowed the selection of 28 putative regulatory variants. Of special interest were BRCA1_ rs8176318 predicted to alter the binding sites of a tumor suppressor miRNA hsa-miR-149 and PALB2_ rs120963 located in tumorigenesis-associated enhancer and predicted to strongly affect the binding of P53. Significant differences in allele frequencies were observed with populations of African and European ancestries for rs8176318 and rs120963 respectively. Our findings will help to better understand the genetic basis of breast cancer by guiding upcoming genome wide studies in the Tunisian population. Putative functional SNPs may be used to develop an efficient polygenic risk score to predict breast cancer risk leading to better disease prevention and management.

1 October 2003 in Cancer/Radiothérapie
Verified
Journal Article
Closed access
LKL Kochbati
L Kochbati
HBH Boussen
H Boussen
FBF Benna
F Benna
ZAZ Belhaj Ali
Z Belhaj Ali
AGA Gammoudi
A Gammoudi
MMM Maalej
M Maalej

1 June 2007 in Gynécologie Obstétrique & Fertilité
Verified
Journal Article
Closed access
JHJ. Ben Hassouna
J. Ben Hassouna
MSM. Slimène
M. Slimène
HBH. Boussen
H. Boussen
HBH. Bouzaiene
H. Bouzaiene
FKF. Khomsi
F. Khomsi
KRK. Rahal
K. Rahal

2 January 2018 in Journal of Immunoassay and Immunochemistry
Verified
Journal Article
Closed access
FMFaouzi Mezni
Faouzi Mezni
MMMona Mlika
Mona Mlika
HBHamouda Boussen
Hamouda Boussen
HGHabib Ghedira
Habib Ghedira
SFSoraya Fenniche
Soraya Fenniche
MLMarie-Anne Loriot
Marie-Anne Loriot
Background: Molecular profile of lung cancer is well known in developed countries. These countries reached the era of liquid biopsies, immunotherapy, and urine circulating tumor DNA. The discrepancies between developed countries and developing ones are becoming deeper. Because of a lack of data in Tunisia, we tried to analyze the molecular profile of non-small-cell carcinomas and to assess the morphologic subtype of adenocarcinomas according to their mutational profile. Methods: We performed molecular analyses in Tunisia and in France of 84 patients who were able to afford the cost of the diagnostic techniques carcinomas diagnosed between 2012 and 2015. The diagnosis was established in our Department of Pathology and the percentage of the tumor cells was estimated by the pathologists. The paraffin-embedded blocks were sent to France, in 41 cases and were analyzed in Tunisia in 43 cases. A next-generation sequencing was performed in France and a real-time polymerase chain reaction (PCR) was performed in our country. Results: During the period of study, 1122 lung cancers were diagnosed and 87 patients were able to afford the molecular analyses cost. The mean age of these patients was 53 years. The sex ratio reached 1.9. The molecular analyses were not performed in three cases because of a low tumor cell rate. EGFR mutations were present in 16 cases: 3 men and 13 women. The adenocarcinomas were classified as acinar in 11 cases and solid in 5 cases. ALK-EML4 translocation was present in six cases. Mutations of BRAF, KRAS, P53, and ERBB4 genes were, respectively, detected in two cases, five cases (3 codon 12), three cases, and one case. Conclusion: This study made us wonder about the possibility of implementing molecular techniques in low-income countries and about the necessity of optimizing the financial resources.